Multiple biomarker 5FU pharmacogenomic test

About EDX Medical

EDX Medical is a UK-listed diagnostics company founded in 2019, specializing in precision testing for cancer, cardiovascular, and infectious diseases. Its strategy is built on a hybrid model of in-house development and strategic partnerships, notably with Caris Life Sciences and Thermo Fisher Scientific, to distribute and co-develop advanced molecular profiling and functional assays. The company is transitioning from a distributor to a developer, with a pipeline of novel tests and a planned launch of an advanced bowel cancer service in 2026, positioning itself at the intersection of digital and laboratory-based diagnostics.

Therapeutic Areas